News
Atossa Therapeutics advances Z-endoxifen for ER+/HER2- metastatic breast cancer, receiving FDA support for dose optimization ...
Could Aravind Srinivas have achieved his full potential by remaining in India instead of moving to Silicon Valley? The ...
Sound Blade Medical, Inc., a leader in handheld histotripsy therapy, today announced the appointment of Neil Barman, M.D. as Chief Executive Officer. Dr. Barman, a physician-executive with more than ...
This content is brought to you by BULLS N’ BEARS NeuroScientific Biopharmaceuticals has made a second heavy-hitting appointment in less than a week, bringing in experienced Melbourne-based executive ...
Vinay Prasad resigns from the FDA after backlash over vaccine restrictions and gene therapy decisions. Political pressure cited in sudden departure.
NeuroScientific Biopharmaceuticals is transferring its patented tech to one of Australia’s most experienced stem cell ...
A controversial hematologist-oncologist who joined FDA this spring and quickly became its top regulator has left the ...
Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...
Dr. Vinay Prasad, the chief scientific officer at the Food and Drug Administration, has resigned after only three months in ...
Vinay Prasad, the top vaccine regulator and chief scientific officer at the Food and Drug Administration (FDA) and a critic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results